In the latest trading session, Thermo Fisher Scientific (TMO) closed at $562.97, marking a +1.41% move from the previous day.
Thermo Fisher's (TMO) latest collaboration with ArsenalBio supports the latter's clinical manufacturing of autologous T-cell therapies for advanced cancer treatment.
Thermo Fisher's (TMO) new cell therapy facility at UCSF is likely to accelerate the development of advanced therapies.